Skip to contentB
Biofrontera Inc.
B
BFRIBiofrontera Inc. Q2 2026 · 10-Q
Revenue$12.00M$12.00M+32.9% vs Q2 2025 Net Income-$604.00K-$604.00KN/M vs Q2 2025 EPS Diluted-$0.05-$0.05N/M vs Q2 2025 Operating Income-$524,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,658,000N/M Margins · derivedOperating margin-4.4%+51.9 pt vs Q2 2025
Net margin-5.0%+53.9 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end